• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926008300
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Intimal Dissection (1333)
Date of Event 10/30/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: the device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The investigation conclusion is anticipated procedural complication as the event is due to a known physiological effect of the procedure noted within the directions for use, and/or device labeling.(b)(4).
 
Event or Problem Description
Same case as mdr id: 2134265-2017-11815.It was reported that vessel dissection occurred.In (b)(6) 2017, clinical status assessment indicated the patient's qualifying condition was unstable angina and the patient was referred for elective cardiac catheterization.The target lesion was located in the proximal left anterior descending (lad) with 75% stenosis and was 24mm long with a reference vessel diameter of 3.00mm.The target lesion was treated with direct placement of 3.00x24mm and 3.00x8mm study stents.Following post dilatation, the residual stenosis was 0%.On the same day, a dissection was noted at the proximal lad and an interventional procedure was performed.One day, post procedure, the patient was discharged on dual antiplatelet therapy.
 
Additional Manufacturer Narrative
(b)(4).
 
Event or Problem Description
It was further reported that the 3.00x24mm study stent caused the dissection which was treated with the 3.00x8mm study stent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Common Device Name
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key7081895
Report Number2134265-2017-11816
Device Sequence Number13771275
Product Code NIQ
UDI-Device Identifier08714729839996
UDI-Public08714729839996
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P150003
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/06/2018
Device Model NumberH7493926008300
Device Catalogue Number39260-0830
Device Lot Number0020267895
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 11/13/2017
Supplement Date Received by Manufacturer12/11/2017
Initial Report FDA Received Date12/05/2017
Supplement Report FDA Received Date12/28/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age81 YR
-
-